An Extension of Protocol NS-0100-01 to Evaluate the Safety and Effect of Various Fixed-Dose Leucine and Metformin Combinations (NS-0100) Versus Standard Metformin Mono-therapy on Glycemic Control in Subjects With Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Leucine/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 27 Jun 2016 Status changed from active, no longer recruiting to completed.
- 20 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015, according to ClinicalTrials.gov record.
- 20 Aug 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Sep 2015, according to ClinicalTrials.gov record.